HTIC, Inc: Clinical Trials

1 trial sponsored by HTIC, Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow HTIC, Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
HT31-1, Saline (0.9%, sterile, for infusion) - ARDS (Acute Respiratory Distress Syndrome)
Phase 1RecruitingHTIC, Inc242026-05-282026-09-16

Conditions studied

Acute Lung Injury (1)  ·  Respiratory Distress Syndrome (1)

Interventions

Sodium Chloride (1)

Countries

United States (1)

Top investigators

Jianjie Ma, PhD (1)